Bolt Biotherapeutics, Inc.

BOLT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Mar 12, 2026 8-K
SCHEDULE 13D/A Feb 26, 2026
SCHEDULE 13D/A Feb 17, 2026
SCHEDULE 13G/A Feb 13, 2026
4 Feb 4, 2026 4
4 Feb 4, 2026 4
4 Feb 4, 2026 4
4 Dec 16, 2025 4
4 Dec 16, 2025 4
4 Dec 16, 2025 4
4 Dec 16, 2025 4
4 Dec 16, 2025 4
4 Dec 16, 2025 4
4 Dec 16, 2025 4
4 Dec 16, 2025 4
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
10-Q Nov 12, 2025 10-Q
8-K Nov 12, 2025 8-K
4 Oct 24, 2025 4
4 Oct 24, 2025 4
4 Oct 24, 2025 4
8-K Oct 2, 2025 8-K
SCHEDULE 13G/A Aug 14, 2025
10-Q Aug 14, 2025 10-Q
← Newer Page 2 of 12 · 296 filings Older →